Gastric Neuroendocrine Tumor G1
specificA well-differentiated, low-grade neuroendocrine neoplasm that arises from the stomach. Most cases arise from the corpus-fundus region. The mitotic count is less than 2 per 2 mm2 and the Ki-67 index is less than 3%. It may be associated with autoimmune chronic atrophic gastritis, multiple endocrine neoplasia type 1, or it may be sporadic.
31
Centers
31
Active Trials
—
Cancer Funding
Top Centers for Gastric Neuroendocrine Tumor G1(31)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 51.6 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 51.6 |
| 3 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 51.6 |
| 4 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 51.6 |
| 5 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 51.6 |
| 6 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 51.6 |
| 7 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 51.6 |
| 8 | NCI Comprehensive Active Research Program | 51.6 |
| 9 | NCI Comprehensive Active Research Program | 51.6 |
| 10 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.6 |
| 11 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 51.6 |
| 12 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.6 |
| 13 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 51.6 |
| 14 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 51.6 |
| 15 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 51.6 |
| 16 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.6 |
| 17 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 51.6 |
| 18 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 51.6 |
| 19 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 51.6 |
| 20 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 51.6 |
| 21 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 51.6 |
| 22 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.6 |
| 23 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 51.6 |
| 24 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 51.6 |
| 25 | Boston University Cancer CenterBoston, MA Active Research Program | 51.6 |
| 26 | Active Research Program | 51.6 |
| 27 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.6 |
| 28 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.6 |
| 29 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 51.6 |
| 30 | Active Research Program | 51.6 |
| 31 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 51.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →